Mast Therapeutics Price Prediction

Mast Therapeutics -- USA Stock  

USD 0.12  0.01  7.69%

Macroaxis is not in business of monitoring Mast Therapeutics headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with Mast Therapeutics brand which may create opportunities for some arbitrage if properly timed. With Mast Therapeutics hype-based prediction module you can estimate the value of Mast Therapeutics from the prospective of Mast Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on Mast Therapeutics over a specific investment horizon. Please see also Mast Therapeutics Basic Forecasting Models to cross-verify your projections.
 Time Horizon     30 Days    Login   to change

Mast Therapeutics After-Hype Price Density Analysis

 Next price density 
Expected price to next headline

Mast Therapeutics Estimiated After-Hype Price Volatility

April 22, 2018
Current Value
After-hype Price
Target Price Odds
 Above  Below  
Mast Therapeutics is abnormally risky asset. Analysis and calculation of next after-hype price of Mast Therapeutics is based on 2 months time horizon.

Mast Therapeutics Next Price Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.28% 1.52% 0.00%  0.09% 0 Events / Month3 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Mast Therapeutics Hype Timeline

Mast Therapeutics is now traded for0.12. This company stock is not elastic to its hype. The average elasticity to hype of competition is -0.09. Mast Therapeutics is projected not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is projected to be very small where as daily expected return is now at 0.28%. The volatility of relative hype elasticity to Mast Therapeutics is about 458.52%%. The volatility of related hype on Mast Therapeutics is about 458.52% with expected price after next announcement by competition of 0.03. About 23.0% of the company shares are owned by institutional investors. The company recorded loss per share of 0.17. Mast Therapeutics had not issued any dividends in recent years. This company had 1:25 split on April 26, 2010. Given the investment horizon of 30 days, the next projected press release will be uncertain.
Please see also Mast Therapeutics Basic Forecasting Models to cross-verify your projections.

Mast Therapeutics Related Hype Analysis

At Risk
NantKwest 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
DelMar Pharmaceuticals(0.06) 1 per month 3.07  0.0192  8.35 (5.45)  19.38 
Dimension Therapeutics 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
Denali Therapeutics(1.41) 2 per month 0.00 (0.0961)  6.42 (5.25)  19.35 
VBI Vaccines 0.00 0 per month 0.00 (0.0731)  5.50 (5.40)  13.72 
Vascular Biogenics Ltd(0.025) 2 per month 0.00 (0.16)  5.69 (5.97)  70.95 
Vericel Corporation 0.1 2 per month 2.52  0.19  11.11 (4.50)  46.82 
Dova Pharmaceuticals(1.79) 2 per month 0.00 (0.20)  4.76 (5.99)  13.44 
Dicerna Pharmaceuticals(0.15) 2 per month 4.30  0.0885  9.85 (8.93)  22.36 
DURECT Corporation 0.02 1 per month 2.81  0.40  8.20 (2.68)  23.21 

Contributor Headline

Latest Prospective on Mast Therapeutics
Mast Therapeutics
  a day ago at Macroaxis
Filed for Hawkins Richard J
Fifth Third exotic insider transaction detected
April 23, 2018 for Alonso Steven
Sale by Deborah LaPinska of 200 shares of PGT Innovations
April 21, 2018 for Deborah LaPinska
View All Premium Stories  

Generate Optimal Portfolios

Align your risk and return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Mast Therapeutics Basic Forecasting Models to cross-verify your projections. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.